项目编号 PRJCA030028
项目标题 Dexmedetomidine Decreases Cerebral Hyperperfusion Incidence Following Carotid Stenting: A Double-blind Randomized Controlled Trial
涉及领域 Medical
数据类型 metabonomics
物种名称 Homo sapiens
描述信息 The matrix was imported in R to carry out Principle Component Analysis (PCA) to observe the overall distribution among the samples and the stability of the whole analysis process. Orthogonal Partial Least-Squares-Discriminant Analysis (OPLS-DA) and Partial Least-Squares-Discriminant Analysis (PLS-DA) were utilized to distinguish the metabolites that differ between groups. To prevent overfitting, 7-fold cross-validation and 200 Response Permutation Testing (RPT) were used to evaluate the quality of the model. Variable Importance of Projection (VIP) values obtained from the OPLS-DA model were used to rank the overall contribution of each variable to group discrimination. A two-tailed Students T-test was further used to verify whether the metabolites of difference between groups were significant.Differential metabolites were selected with VIP values greater than 1.0 and p-values less than 0.05.
样品范围 Monoisolate
发布日期 2024-09-10
出版信息
PubMed ID 文章标题 杂志名称 Doi 发表年份
Dexmedetomidine decreases cerebral hyperperfusion incidence following carotid stenting: A double-blind, randomized controlled trial Med 10.1016/j.medj.2024.09.012 2024
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
National Natural Science Foundation of China No.82271288
Henan Provincial Science and Technology Research Project No.242300421192
Henan Provincial Science and Technology Research Project JQRC2023004
提交者 Enqiang Chang (changenqiang@zzu.edu.cn)
提交单位 People's Hospital of Zhengzhou
提交日期 2024-09-10

项目包含数据信息

资源名称 描述